First evidence of oncologic neuropathic pain prevalence after screening 8615 cancer patients. Results of the On study
García de Paredes, M.L., del Moral González, F., Martínez del Prado, P., Martí Ciriquián, J.L., Enrech Francés, S., Cobo Dols, M., Esteban González, E., Ortega Granados, A.L., Majem Tarruella, M., Cumplido Burón, J.D., Gascó Hernández, A., López Miranda, E., Ciria Santos, J.P., de Castro Carpeño, F.J.
Published in Annals of oncology (01.04.2011)
Published in Annals of oncology (01.04.2011)
Get full text
Journal Article
Association of efficacy and immune-related adverse events (irAEs) in patients with NSCLC receiving immune-checkpoint inhibitors (ICIs)
Riudavets Melia, M., Gabriela Sullivan, I., Barba Joaquín, A., Anguera Palacios, G., del Carpio, L.P., Molto Valiente, C., Camacho Arellano, S.D., Moron Asensio, S., Gomila Pons, P., Andres Granyó, M., Castillo Villegas, D., Facundo Molas, C., Garcia Planella, E., González Blanco, C., Barnadas Molins, A., Gich Saladich, I., Majem Tarruella, M.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Homology-directed repair (HDR)-defective lung adenocarcinomas (LUACs) in circulating tumor DNA (ctDNA)
Karachaliou, N., Lefterova, M., Draper, J.F., Molina, M.-A., Chaib, I., Palmero, R., Taus, A., Viteri, S., González Cao, M., Majem Tarruella, M., Carcereny Costa, E., Moran, T., Garde Noguera, J., Felip Font, E., Olsen, S., Jackson, M., Sampayo, M., Faull, I., Dix, D., Rosell, R.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
GECP 1605/NIVEX TRIAL nivolumab in the real world: The SPANISH expanded access program experience in pretreated advanced NSCLC
Majem Tarruella, M., Campillo, J., Grau Béjar, J.F., Carcereny, E., Bernabe Caro, R., Garcia, Y., Artal-Cortes, A., González Cao, M., Lianes, P., Paredes Lario, A., Sereno Moyano, M., Mielgo Rubio, X., Macias, J.A., Provencio Pulla, M., Rodriguez-Abreu, D.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Association of immune-related adverse (irAEs) with immune-checkpoint inhibitors (ICIs) efficacy in solid tumors
Riudavets Melia, M., del Carpio, L.P., Gabriela Sullivan, I., Barba Joaquín, A., Maroto Rey, P., Anguera Palacios, G., Páez López-Bravo, D., Callejo Pérez, A., González Blanco, C., Castillo Villegas, D., Facundo Molas, C., Garcia Planella, E., Genua Trullos, I., López Pousa, A., Sebio García, A., Martín Lorente, C., Virgili Manrique, A.C., Gallego Rubio, O., Barnadas Molins, A., Majem Tarruella, M.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
11P Results of a phase II study investigating eftilagimod alpha (soluble LAG-3 protein) and pembrolizumab in second-line PD-1/PD-L1 refractory metastatic non-small cell lung carcinoma pts
Krebs, M.G., Majem Tarruella, M., Forster, M., Peguero, J.A., Clay, T., Felip, E., Iams, W., Roxburgh, P., Doger de Spéville, B., Bajaj, P., Mueller, C., Triebel, F.
Published in Annals of oncology (01.04.2022)
Published in Annals of oncology (01.04.2022)
Get full text
Journal Article
LBA5 Long-term tolerability of adjuvant osimertinib in patients with resected EGFR-mutated (EGFRm) stage IB–IIIA non-small cell lung cancer (NSCLC) from ADAURA
John, T., Grohe, C., Goldman, J., De Marinis, F., Kato, T., Wang, Q., Choi, J-H., Melotti, B., Fidler, M., Sainsbury, L., Stachowiak, M., Taggart, S., Wu, Y-L., Tsuboi, M., Herbst, R.S., Majem Tarruella, M.
Published in Annals of oncology (01.11.2022)
Published in Annals of oncology (01.11.2022)
Get full text
Journal Article
508MO Tarlatamab for patients (pts) with previously treated small cell lung cancer (SCLC): Primary analysis of the phase II DeLLphi-301 study
Paz-Ares, L., Ahn, M-J., Felip, E., Handzhiev, S., Korantzis, I., Izumi, H., Ohashi, K., Majem Tarruella, M., Wolf, J., Reck, M., Hummel, H-D., Blackhall, F., Dingemans, A-M.C., Owonikoko, T.K., Ramalingam, S.S., Sands, J., Jiang, T., Mukherjee, S., Anderson, E., Cho, B.C.
Published in Annals of oncology (01.11.2023)
Published in Annals of oncology (01.11.2023)
Get full text
Journal Article
1204P Cost-benefit analysis of ALK diagnosis in patients with non-small cell lung cancer in Spain
Granados, A.L. Ortega, Todo, F. Rojo, Álvarez, R. Álvarez, Tarruella, M. Majem, Ruiz de Alda Iparraguirre, L., Verdes-Montenegro, J.F. García, Flores, R. Gordo, González-Domínguez, A., Markova, Y. Ivanova, San Cristóbal, R. Sánchez
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
131P Predictive factors of response to PD-(L)1 inhibitors in patients with advanced non-small cell lung (NSCLC) and high PD-L1 expression
Ioaquín, A. Barba, Piedra, A., Mosquera, J., Riudavets, M., Gomez-Randulfe, M.I., Campelo, M.R. Garcia, Sullivan, I.G., Serra, J., Aguado, M., Tarruella, M. Majem
Published in Journal of thoracic oncology (01.04.2021)
Published in Journal of thoracic oncology (01.04.2021)
Get full text
Journal Article
P48.04 IMfirst; Phase IIIB Safety Study of Atezolizumab Plus Chemotherapy in a Real World Population of Untreated ES-SCLC
Campelo, R. Garcia, De Castro Carpeño, J., Dols, M. Cobo, Vega, A. Moreno, Tarruella, M. Majem, Aperribay, E. Arriola, Crama, L., Gracia, P. Ruiz, Gómez, M. Dómine
Published in Journal of thoracic oncology (01.03.2021)
Published in Journal of thoracic oncology (01.03.2021)
Get full text
Journal Article
296P Osimertinib as adjuvant therapy in patients (pts) with resected EGFR-mutated (EGFRm) stage IB-IIIA non-small cell lung cancer (NSCLC): Updated results from ADAURA
Wu, Y-L., Tsuboi, M., Grohe, C., John, T., Majem Tarruella, M., Wang, J., Kato, T., Goldman, J.W., Kim, S-W., Yu, C-J., Vinh Vu, H., Mukhametshina, G., Akewanlop, C., de Marinis, F., Shepherd, F.A., Urban, D., Stachowiak, M., Bolanos, A., Huang, X., Herbst, R.S.
Published in Annals of oncology (01.11.2022)
Published in Annals of oncology (01.11.2022)
Get full text
Journal Article
42TiP A multicenter, randomized, double-blind phase III study of HBI-8000 combined with nivolumab versus placebo with nivolumab in patients with unresectable or metastatic melanoma not previously treated with PD-1 or PD-L1 inhibitors
Khushalani, N.I., Shue, H., Gedye, C., Mazumder, A., Sharma, S., Eastgate, M., Majem Tarruella, M., Antonanzas Basa, M., Montaudie, H., Marais-Nieman, R., de la Cruz Merino, L., Clements, A., Mortier, L., Jameson, M., Shojaei, F., Ning, J., Aiyer, L., Gillings, M., Kabbinavar, F., Ascierto, P.
Published in Annals of oncology (01.11.2022)
Published in Annals of oncology (01.11.2022)
Get full text
Journal Article
P2.14-01 Patient-Reported Outcomes from IMfirst: Chemotherapy Plus Atezolizumab in a Real-World Setting of Extensive-Stage SCLC
Dómine Gómez, M., Cobo Dols, M., de Castro, J., Moreno Vega, A., Ponce Aix, S., Arriola, E., Carcereny, E., Majem Tarruella, M., Huidobro Vence, G., Esteban González, E., Fuentes Pradera, J., Ortega Granados, A.L., Guillot Morales, M., Massuti Sureda, B., Vilà, L., Blasco Cordellat, A., Fajardo, C.A., Crama, L., Lerones, N., García Campelo, R.
Published in Journal of thoracic oncology (01.11.2023)
Published in Journal of thoracic oncology (01.11.2023)
Get full text
Journal Article
P2.14-04 Treatment Beyond Progression with Atezolizumab in Extensive-Stage SCLC: Exploratory Analysis from the IMfirst Study
García-Campelo, R., Dómine Gómez, M., de Castro, J., Moreno Vega, A., Ponce Aix, S., Arriola, E., Carcereny, E., Majem Tarruella, M., Huidobro Vence, G., Esteban González, E., Fuentes Pradera, J., Ortega Granados, A.L., Guillot Morales, M., Massuti Sureda, B., Vilà, L., Blasco Cordellat, A., Fajardo, C.A., Crama, L., Lerones, N., Cobo Dols, M.
Published in Journal of thoracic oncology (01.11.2023)
Published in Journal of thoracic oncology (01.11.2023)
Get full text
Journal Article
989P Sotorasib in advanced KRAS p.G12C-mutated non-small cell lung cancer (NSCLC): Safety and efficacy data from the global expanded access program (EAP)
Awad, M., Pelizzari, G., Stevenson, J.P., Majem Tarruella, M., Ferreira, C.G.M., Petty, W.J., Arriola, E., de Castro, J., Morbeck, I., Bauman, J.R., Toschi, L., Zer, A., Metro, G., Kalmadi, S., Azkárate Martínez, A., Xia, C., Meloni, A., Obiozor, C., Maimon, N., Novello, S.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
1098P Predictive factors of efficacy to pembrolizumab in advanced NSCLC patients with high PD-L1 expression
Piedra, A., Barba Joaquín, A., Mosquera Martinez, J., Fernandez Bruno, M., Cordeiro González, P., Sullivan, I.G., Riudavets Melia, M., Aguado Sorolla, M., Gallardo Melo, P., Martin Cullell, B., Gavira, J., Tapia, J.C., Romano, A., Bosma, F., Sanchez Del Rio, S., Sanz Beltran, J., Molina Pérez, M.A., Serra López, J., Garcia Campelo, M.R., Majem Tarruella, M.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
LBA47 Osimertinib as adjuvant therapy in patients (pts) with resected EGFR-mutated (EGFRm) stage IB-IIIA non-small cell lung cancer (NSCLC): Updated results from ADAURA
Tsuboi, M., Wu, Y-L., Grohe, C., John, T., Tarruella, M. Majem, Wang, J., Kato, T., Goldman, J.W., Kim, S-W., Yu, C-J., Vu, H. Vinh, Mukhametshina, G., Akewanlop, C., de Marinis, F., Shepherd, F.A., Urban, D., Stachowiak, M., Bolanos, A.L., Huang, X., Herbst, R.S.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
1532P Phase IIIb study of durvalumab plus platinum-etoposide in first-line treatment of extensive-stage small cell lung cancer (CANTABRICO): Preliminary efficacy results
Isla, D., Arriola, E., Garcia Campelo, M.R., Diz Tain, P., Marti Blanco, C., Lopez-Brea Piqueras, M.M., Moreno Vega, A.L., Leon Mateos, L.A., Oramas Rodriguez, J.M., Gutierrez Calderon, V., Majem Tarruella, M., Sanchez Hernandez, A., Aguado de la Rosa, C., Alvarez Cabellos, R., Marti Ciriquian, J.L., Moreno Paul, A., Firvida Perez, J.L., Callejo Mellén, Á., Baez, L., Paz-Ares, L.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
848P Second-line systemic treatment for patients with advanced melanoma: Results from the prospective real-world study GEM1801
Marquez-Rodas, I., Berciano Guerrero, M.A., Muñoz Couselo, E., Soria, A., Cerezuela-Fuentes, P., Manzano Mozo, J.L., Gutierrez Sanz, L., Crespo, G., Puértolas, T., Garcia Castano, A., Aguado de la Rosa, C., Espinosa, E., Majem Tarruella, M., López Castro, R., Ayala de Miguel, P., Medina Martinez, J., Fernández Morales, L.A., Bellido Hernández, L., Berrocal, A., Martín Algarra, S.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article